US2014336160A1PendingUtilityA1

Novel glucocorticold receptor agonists

Assignee: PFIZERPriority: Nov 30, 2007Filed: Jul 23, 2014Published: Nov 13, 2014
Est. expiryNov 30, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61P 37/02A61P 37/08A61P 43/00A61P 5/46A61P 29/00A61P 27/14A61P 27/02A61P 17/06A61P 11/04A61P 1/00A61P 1/04A61P 11/06A61P 17/00A61P 11/02A61P 17/04A61P 19/02A61P 11/00C07J 71/0031A61K 45/06C07J 7/008
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to novel glucocorticoid receptor agonists of formula (I): and to processes and intermediates for their preparation. The present invention also relates to pharmaceutical compositions containing these compounds, to their combination with one or more other therapeutic agents, as well as to their use for the treatment of a number of inflammatory and allergic diseases, disorders and conditions.

Claims

exact text as granted — not AI-modified
1 . A compound of formula (I): 
       
         
           
           
               
               
           
         
       
       wherein R 1  is 
       
         
           
           
               
               
           
         
         wherein * represent the attachment point of R 1  to the carbon of the phenyl cycle; 
         or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate of said compound or salt. 
       
     
     
         2 - 4 . (canceled) 
     
     
         5 . A pharmaceutical composition comprising an effective amount of a compound of the formula (I) as described in  claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 
     
     
         6 - 18 . (canceled)

Join the waitlist — get patent alerts

Track US2014336160A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.